Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
5.76
-0.38 (-6.19%)
May 13, 2025, 4:00 PM - Market closed

Coya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
969610712--
Market Cap Growth
-25.30%-10.29%769.50%---
Enterprise Value
61659624--
Last Close Price
5.765.737.414.74--
PS Ratio
24.7026.9417.78---
PB Ratio
2.892.422.99-1.46--
P/TBV Ratio
2.892.422.99---
EV/Sales Ratio
16.5018.2015.97---
Debt / Equity Ratio
----1.54--
Asset Turnover
0.100.080.24---
Quick Ratio
8.1910.227.941.553.7819.51
Current Ratio
8.8411.598.151.883.9919.57
Return on Equity (ROE)
-52.11%-39.57%-58.64%--81.90%-
Return on Assets (ROA)
-32.06%-25.15%-18.53%-88.03%-44.96%-
Return on Capital (ROIC)
-36.96%-28.63%-22.88%-141.30%-50.96%-
Earnings Yield
-17.79%-15.54%-7.49%-99.77%--
FCF Yield
-15.84%-10.75%-10.48%-58.99%--
Buyback Yield / Dilution
-39.27%-49.93%-292.40%-0.01%-40.88%-
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q